Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01585779
Other study ID # 10030481DOC
Secondary ID
Status Completed
Phase N/A
First received April 18, 2012
Last updated May 4, 2017
Start date May 2012
Est. completion date June 2016

Study information

Verified date May 2017
Source Medtronic Cardiovascular
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.


Description:

The primary goal of the TV repair procedure is to relieve patients from TV insufficiency or reduce TV stenosis. This study will evaluate the hemodynamic efficacy of the Contour 3D® and Tri-Ad® ring and characterize the effect of the TV repair through assessment of right atrial size and right ventricular function. Additionally, this study will characterize the patient population for whom a Contour 3D® or Tri-Ad® ring is chosen to repair TV insufficiency. Health status and adverse events (AE) will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Subject or legal guardian willing and able to sign and date the Informed Consent Form (and Authorization to Use and Disclose Health Information Form, if applicable)

- Subject indicated for a concomitant surgical repair of the TV

- Subject is willing to return for required follow-up visits to the hospital where the implantation originally occurred

Exclusion Criteria:

- Subject with a degenerative TV condition

- Subject with primary TV regurgitation

- Subject with a previous TV repair or replacement

- Subject indicated for a stand-alone TV repair

- Subject currently participating in an investigational drug or another device study

- Subject with life expectancy of less than one year

- Subject is pregnant or desires to be pregnant within 12 months following implantation

- Subject is under 18 or over 85 years of age

- Subject with active endocarditis

- Subject with valvular retraction with severely reduced mobility

- Subject with a heavily calcified TV

Study Design


Intervention

Device:
Contour 3D® implant for tricuspid valve repair
Tricuspid annuloplasty ring
Tri-Ad® implant for tricuspid valve repair
Tricuspid annuloplasty ring

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan
United States Mission Hospital Research Institute Asheville North Carolina
United States Florida Heart & Vascular Care at Aventura Aventura Florida

Sponsors (1)

Lead Sponsor Collaborator
Medtronic Cardiovascular

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the Degree of Tricuspid Regurgitation The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment.
Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant.
Preimplant through Discharge
Primary Change in the Degree of Tricuspid Regurgitation The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment.
Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant.
Preimplant through 6 Months
Primary Change in the Degree of Tricuspid Regurgitation The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment.
Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant.
Preimplant through 12 Months
Primary The Mean Gradient Across the Tricuspid Valve The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant Discharge
Primary The Mean Gradient Across the Tricuspid Valve The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant 6 months
Primary The Mean Gradient Across the Tricuspid Valve The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant 12 months
Primary Change in the Degree of TV Leaflet Coaptation Length The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant. Preimplant through Discharge
Primary Change in the Degree of TV Leaflet Coaptation Length The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant. Preimplant through 6 Months
Primary Change in the Degree of TV Leaflet Coaptation Length The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant. Preimplant through 12 Months
Primary Change in the Degree of TV Leaflet Tethering Height The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant. Preimplant through Discharge
Primary Change in the Degree of TV Leaflet Tethering Height The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant. Preimplant through 6 Months
Primary Change in the Degree of TV Leaflet Tethering Height The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant Preimplant through 12 Months
Secondary Change in the Right Ventricle (RV) Diastolic Area The secondary objective is the evaluation of effect of TV repair with the study ring on Right ventricle (RV) diastolic area at end diastole. Change in the Right ventricle (RV) diastolic area from preimplant through 12 months post-implant. Preimplant through Discharge
Secondary Change in the Right Ventricle (RV) Diastolic Area The secondary objective is the evaluation of effect of TV repair with the study ring on Right ventricle (RV) diastolic area at end diastole. Change in the Right ventricle (RV) diastolic area from preimplant through 12 months post-implant. Preimplant through 6 Months
Secondary Change in the Right Ventricle (RV) Diastolic Area The secondary objective is the evaluation of effect of TV repair with the study ring on Right ventricle (RV) diastolic area at end diastole. Change in the Right ventricle (RV) diastolic area from preimplant through 12 months post-implant Preimplant through 12 Months
Secondary Change in the Tricuspid Annular (Basal) Diameter The secondary objective is the evaluation of effect of TV repair with the study ring on Tricuspid annular (basal) diameter. Change in the tricuspid annular (basal) diameter from preimplant through 12 months post-implant Preimplant through Discharge
Secondary Change in the Tricuspid Annular (Basal) Diameter The secondary objective is the evaluation of effect of TV repair with the study ring on Tricuspid annular (basal) diameter. Change in the tricuspid annular (basal) diameter from preimplant through 12 months post-implant Preimplant through 6 Months
Secondary Change in the Tricuspid Annular (Basal) Diameter The secondary objective is the evaluation of effect of TV repair with the study ring on Tricuspid annular (basal) diameter. Change in the tricuspid annular (basal) diameter from preimplant through 12 months post-implant Preimplant through 12 Months
Secondary Change in the RV Fractional Area The secondary objective is the evaluation of effect of TV repair with the study ring on RV fractional area. Change in the RV fractional area preimplant through 12 months post-implant. Preimplant through Discharge
Secondary Change in the RV Fractional Area The secondary objective is the evaluation of effect of TV repair with the study ring on RV fractional area. Change in the RV fractional area preimplant through 12 months post-implant. Preimplant through 6 Months
Secondary Change in the RV Fractional Area The secondary objective is the evaluation of effect of TV repair with the study ring on RV fractional area. Change in the RV fractional area preimplant through 12 months post-implant. Preimplant through 12 Months
Secondary Demographic Data Characterize the patient population for which an annuloplasty ring is chosen to repair TV insufficiency and assess the effect of TV repair with the study ring on the tricuspid valve functional status Baseline
Secondary Change in New York Heart Association (NYHA) Classification Assess the effect of TV repair with the study ring on the tricuspid valve functional status by analysis of the New York Heart Association (NYHA) classification from pre-implant through 12 months post-implant. Preimplant through Discharge
Secondary Change in New York Heart Association (NYHA) Classification Assess the effect of TV repair with the study ring on the tricuspid valve functional status by analysis of the New York Heart Association (NYHA) classification from pre-implant through 12 months post-implant. Preimplant through 6 months
Secondary Change in New York Heart Association (NYHA) Classification . Assess the effect of TV repair with the study ring on the tricuspid valve functional status by analysis of the New York Heart Association (NYHA) classification from pre-implant through 12 months post-implant. Preimplant through 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06196684 - Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
Not yet recruiting NCT03278418 - Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach N/A
Terminated NCT03632967 - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System N/A
Active, not recruiting NCT05724225 - "Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A
Completed NCT01444222 - Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart
Recruiting NCT04653428 - German Registry for Transcatheter Tricuspid Valve Interventions
Recruiting NCT02574650 - Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. N/A
Completed NCT04945005 - Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry
Recruiting NCT03225612 - Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) N/A
Withdrawn NCT03166488 - MRE Evaluation of Liver Stiffness After Tricuspid Valvular Repair N/A
Completed NCT03604484 - Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery N/A
Completed NCT01537458 - Long-term Outcome After Isolated Tricuspid Valve Repair
Recruiting NCT05913908 - EFS of the DUO System for Tricuspid Regurgitation (TANDEM II) N/A
Recruiting NCT04436653 - THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve N/A
Completed NCT01334801 - Biomarkers in Aortic Stenosis - B.A.S.S.
Recruiting NCT04735003 - Transcatheter Interventions for Tricuspid Insufficiency in Italy
Recruiting NCT02314897 - Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study N/A
Completed NCT01532921 - EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty
Active, not recruiting NCT04614402 - Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System

External Links